doi: 10.1002/9781118971758.ch29 23 BehrensM
no returns accepted once compounded medication has shipped and been delivered, per federal compounding rules
doi: 10.1016/j.jep.2014.09.049 261
Cleanse, moisturize, and treat only where needed
Tirzepatide is a dual-agonist , meaning it works by targeting two hormones: GLP-1: helps regulate appetite, blood sugar, and digestion GIP: supports insulin response and reduces nausea Retatrutide is a triple-agonist , meaning it targets three hormones: GLP-1: helps regulate appetite, blood sugar, and digestion GIP: supports insulin response and reduces nausea Glucagon: affects energy use and fat metabolism Early studies show that retatrutide may be more successful than tirzepatide at managing diabetic kidney disease, as well as for weight control, while tirzepatide may be better at managing blood glucose